A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese Subjects

NCT05297929 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Irbesartan Tablets (0.15g/Tablet)
Under Fasted Condition
Under Fed Condition
Bioequivalence

Interventions

DRUG: Irbesartan Tablet

Sponsor

The Affiliated Hospital of Qingdao University